๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

14 recruiting trials

for Severe Alopecia Areata

A Study to Learn About Litfulo Capsule in People With Severe Alopecia Areata in Routine Clinical Practice. NCT07152119n/a1 site๐Ÿ“ Seoul Pfizer ยท Tests: Litfulo Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata NCT07133308Phase 364 sites๐Ÿ“ Birmingham๐Ÿ“ Scottsdale๐Ÿ“ Bryant Sun Pharmaceutical Industries, Inc. ยท Tests: Deuruxolitinib, Placebo Scalp Hair Metabolomics in Severe Obesity NCT07368842n/a1 site๐Ÿ“ Singapore Singapore General Hospital Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Japanese Adults With Severe Alopecia Areata NCT07617597Phase 318 sites๐Ÿ“ Asahikawa๐Ÿ“ Bunkyล City๐Ÿ“ Ebina Sun Pharma Japan Limited ยท Tests: Deuruxolitinib, Placebo A Study of LAD603 in Adults With Alopecia Areata NCT07311564Phase 21 site๐Ÿ“ Omaha Almirall, S.A. ยท Tests: LAD603, Placebo A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata. NCT07205159Phase 16 sites๐Ÿ“ Saint Leonards๐Ÿ“ Coorparoo๐Ÿ“ South Yarra Forte Biosciences, Inc. ยท Tests: FB102, Placebo A Phase I Study of VC005 Tablets in Adolescent Subjects With Severe Alopecia Areata NCT07762443Phase 11 site๐Ÿ“ Beijing Jiangsu vcare pharmaceutical technology co., LTD ยท Tests: VC005 tablets Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata NCT07749716Phase 21 site๐Ÿ“ Beijing Jiangsu vcare pharmaceutical technology co., LTD ยท Tests: Drug: VC005 tablets, VC005 tablets, VC005 placebo tablets Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration NCT07554222Phase 11 site๐Ÿ“ Shanghai Innovent Biologics (Suzhou) Co. Ltd. ยท Tests: placebo, Baricitinib tablets, IBI3013 A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata NCT06012240Phase 3272 sites๐Ÿ“ Birmingham๐Ÿ“ Glendale๐Ÿ“ Phoenix AbbVie ยท Tests: Upadacitinib, Placebo Safety and Efficacy of Oral NXC-736 in Adult Participants With Moderate and Severe Alopecia Areata NCT06104839Phase 22 sites๐Ÿ“ Seoul๐Ÿ“ Seoul NEXTGEN Bioscience ยท Tests: NXC736, Placebo A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss) NCT07533006Phase 230 sites๐Ÿ“ Fremont๐Ÿ“ Northridge๐Ÿ“ Santa Clarita Eli Lilly and Company ยท Tests: LY4005130, Placebo A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata NCT07772492Phase 313 sites๐Ÿ“ Los Angeles๐Ÿ“ Miami๐Ÿ“ Meridian AbbVie ยท Tests: Upadacitinib, Placebo A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata. NCT07029828Phase 367 sites๐Ÿ“ Irvine๐Ÿ“ Santa Ana๐Ÿ“ Aurora Pfizer ยท Tests: Ritlecitinib higher dose, Ritlecitinib lower dose
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy